Rare coding variants pinpoint genes that control human hematological traits

PLoS Genetics

Volumn 13, Issue 8, 2017, Pages

  Mousas, Abdou ^a,b   Ntritsos, Georgios ^c   Chen, Ming Huei ^d   Song, Ci ^d   Huffman, Jennifer E ^d   Tzoulaki, Ioanna ^c,e   Elliott, Paul ^e   Psaty, Bruce M ^f,g   Auer, Paul L ^h   Johnson, Andrew D ^d   Evangelou, Evangelos ^c,e   Lettre, Guillaume ^a,b   Reiner, Alexander P ^i,j  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

^c UNIVERSITY OF IOANNINA   (Greece)

^d FRAMINGHAM HEART STUDY   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g KAISER PERMANENTE   (United States)

^h UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j Fred Hutchinson Cancer Research Center   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; INTERLEUKIN 33; PLASMINOGEN; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ALLERGIC RHINITIS; ARTICLE; ASTHMA; BLOOD CELL; EOSINOPHIL COUNT; GENE FREQUENCY; GENETIC CODE; GENETIC TRAIT; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HEMATOPOIESIS; HUMAN; MISSENSE MUTATION; PLATELET REACTIVITY; RNA SPLICE SITE; THROMBOCYTE COUNT; BLOOD; DNA SEQUENCE; ENDOMETRIOSIS; FEMALE; GENE LOCUS; GENETIC DATABASE; GENETICS; HUMAN GENOME; MALE; METABOLISM; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; PROTEIN SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

ASTHMA; DATABASES, GENETIC; ENDOMETRIOSIS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; GENE FREQUENCY; GENETIC LOCI; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTERLEUKIN-33; LINEAR MODELS; LOGISTIC MODELS; MALE; MUTATION, MISSENSE; PHENOTYPE; PLASMINOGEN; PLATELET COUNT; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; PROTEIN SPLICING; RHINITIS, ALLERGIC; SEQUENCE ANALYSIS, DNA;

EID: 85028882963     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1006925     Document Type: Article

References (55)

1. Astle WJ, Elding H, Jiang T, Allen D, Ruklisa D, Mann AL, et al. The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. Cell. 2016;167(5):1415–29 e19. doi: 10.1016/j.cell.2016.10.042 27863252.
2. Cohen JC, Boerwinkle E, Mosley TH, Jr.Hobbs HH, Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006;354(12):1264–72. doi: 10.1056/NEJMoa054013 16554528.
3. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH, Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science. 2004;305(5685):869–72. doi: 10.1126/science.1099870 15297675.
4. Do R, Stitziel NO, Won HH, Jorgensen AB, Duga S, Angelica Merlini P, et al. Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. Nature. 2015;518(7537):102–6. doi: 10.1038/nature13917 25487149; PubMed Central PMCID: PMCPMC4319990.
5. Tg, Hdl Working Group of the Exome Sequencing Project NHLBlood ICrosby J, Peloso GM, Auer PL, et al. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med. 2014;371(1):22–31. doi: 10.1056/NEJMoa1307095 24941081; PubMed Central PMCID: PMCPMC4180269.
6. Marouli E, Graff M, Medina-Gomez C, Lo KS, Wood AR, Kjaer TR, et al. Rare and low-frequency coding variants alter human adult height. Nature. 2017;542(7640):186–90. doi: 10.1038/nature21039 28146470; PubMed Central PMCID: PMCPMC5302847.
7. Auer PL, Teumer A, Schick U, O'Shaughnessy A, Lo KS, Chami N, et al. Rare and low-frequency coding variants in CXCR2 and other genes are associated with hematological traits. Nat Genet. 2014. doi: 10.1038/ng.2962 24777453.
8. Group CCHWMeta-analysis of rare and common exome chip variants identifies S1PR4 and other loci influencing blood cell traits. Nat Genet. 2016;48(8):867–76. doi: 10.1038/ng.3607 27399967; PubMed Central PMCID: PMCPMC5145000.
9. Auer PL, Teumer A, Schick U, O'Shaughnessy A, Lo KS, Chami N, et al. Rare and low-frequency coding variants in CXCR2 and other genes are associated with hematological traits. Nat Genet. 2014;46(6):629–34. doi: 10.1038/ng.2962 24777453; PubMed Central PMCID: PMCPMC4050975.
10. Eicher JD, Chami N, Kacprowski T, Nomura A, Chen MH, Yanek LR, et al. Platelet-Related Variants Identified by Exomechip Meta-analysis in 157,293 Individuals. Am J Hum Genet. 2016;99(1):40–55. doi: 10.1016/j.ajhg.2016.05.005 27346686; PubMed Central PMCID: PMCPMC5005441.
11. Chami N, Chen MH, Slater AJ, Eicher JD, Evangelou E, Tajuddin SM, et al. Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits. Am J Hum Genet. 2016;99(1):8–21. doi: 10.1016/j.ajhg.2016.05.007 27346685; PubMed Central PMCID: PMCPMC5005438.
12. Kumar P, Henikoff S, Ng PC, Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073–81. doi: 10.1038/nprot.2009.86 19561590.
13. Adzhubei I, Jordan DM, Sunyaev SR, Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013;Chapter 7:Unit7 20. doi: 10.1002/0471142905.hg0720s76 23315928; PubMed Central PMCID: PMCPMC4480630.
14. Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J, A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310–5. doi: 10.1038/ng.2892 24487276; PubMed Central PMCID: PMC3992975.
15. Kumari S, Chaurasia SN, Nayak MK, Mallick RL, Dash D, Sirtuin Inhibition Induces Apoptosis-like Changes in Platelets and Thrombocytopenia. J Biol Chem. 2015;290(19):12290–9. doi: 10.1074/jbc.M114.615948 25829495; PubMed Central PMCID: PMCPMC4424360.
16. Gieger C, Radhakrishnan A, Cvejic A, Tang W, Porcu E, Pistis G, et al. New gene functions in megakaryopoiesis and platelet formation. Nature. 2011;480(7376):201–8. Epub 2011/12/06. doi: 10.1038/nature10659 22139419; PubMed Central PMCID: PMC3335296.
17. Liongue C, Wright C, Russell AP, Ward AC, Granulocyte colony-stimulating factor receptor: stimulating granulopoiesis and much more. Int J Biochem Cell Biol. 2009;41(12):2372–5. doi: 10.1016/j.biocel.2009.08.011 19699815.
18. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med. 2010;363(13):1211–21. doi: 10.1056/NEJMoa0906312 20860503; PubMed Central PMCID: PMCPMC4260321.
19. Hinds DA, McMahon G, Kiefer AK, Do CB, Eriksson N, Evans DM, et al. A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci. Nat Genet. 2013;45(8):907–11. doi: 10.1038/ng.2686 23817569; PubMed Central PMCID: PMCPMC3753407.
20. Albertsen HM, Chettier R, Farrington P, Ward K, Genome-wide association study link novel loci to endometriosis. PLoS One. 2013;8(3):e58257. 10.1371/journal.pone.0058257. doi: 10.1371/journal.pone.0058257 23472165; PubMed Central PMCID: PMCPMC3589333.
21. Smith D, Helgason H, Sulem P, Bjornsdottir US, Lim AC, Sveinbjornsson G, et al. A rare IL33 loss-of-function mutation reduces blood eosinophil counts and protects from asthma. PLoS Genet. 2017;13(3):e1006659. doi: 10.1371/journal.pgen.1006659 28273074.
22. Lilleyman JS, Constitutional hypoplastic anemia associated with familial "bird-headed" dwarfism (Seckel syndrome). Am J Pediatr Hematol Oncol. 1984;6(2):207–9. 6465473.
23. Patel KV, Semba RD, Ferrucci L, Newman AB, Fried LP, Wallace RB, et al. Red cell distribution width and mortality in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci. 2010;65(3):258–65. doi: 10.1093/gerona/glp163 19880817; PubMed Central PMCID: PMCPMC2822283.
24. Jorgensen AB, Frikke-Schmidt R, Nordestgaard BG, Tybjaerg-Hansen A, Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. N Engl J Med. 2014;371(1):32–41. doi: 10.1056/NEJMoa1308027 24941082.
25. Forrest AR, Kawaji H, Rehli M, et al. A promoter-level mammalian expression atlas. Nature. 2014;507(7493):462–70. doi: 10.1038/nature13182 24670764; PubMed Central PMCID: PMCPMC4529748.
26. Butler M, Morel AS, Jordan WJ, Eren E, Hue S, Shrimpton RE, et al. Altered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205-DCL-1 fusion protein upon dendritic cell maturation. Immunology. 2007;120(3):362–71. doi: 10.1111/j.1365-2567.2006.02512.x 17163964; PubMed Central PMCID: PMCPMC2265885.
27. Kato M, Khan S, Gonzalez N, O'Neill BP, McDonald KJ, Cooper BJ, et al. Hodgkin's lymphoma cell lines express a fusion protein encoded by intergenically spliced mRNA for the multilectin receptor DEC-205 (CD205) and a novel C-type lectin receptor DCL-1. J Biol Chem. 2003;278(36):34035–41. doi: 10.1074/jbc.M303112200 12824192.
28. Burgener R, Wolf M, Ganz T, Baggiolini M, Purification and characterization of a major phosphatidylserine-binding phosphoprotein from human platelets. Biochem J. 1990;269(3):729–34. 2390065; PubMed Central PMCID: PMCPMC1131648.
29. Baig A, Bao X, Wolf M, Haslam RJ, The platelet protein kinase C substrate pleckstrin binds directly to SDPR protein. Platelets. 2009;20(7):446–57. doi: 10.3109/09537100903137314 19852682.
30. Chambers JC, Zhang W, Sehmi J, Li X, Wass MN, Van der Harst P, et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet. 2011;43(11):1131–8. doi: 10.1038/ng.970 22001757; PubMed Central PMCID: PMCPMC3482372.
31. Chen L, Kostadima M, Martens JH, Canu G, Garcia SP, Turro E, et al. Transcriptional diversity during lineage commitment of human blood progenitors. Science. 2014;345(6204):1251033. doi: 10.1126/science.1251033 25258084; PubMed Central PMCID: PMCPMC4254742.
32. Wang CY, Meynard D, Lin HY, The role of TMPRSS6/matriptase-2 in iron regulation and anemia. Front Pharmacol. 2014;5:114. doi: 10.3389/fphar.2014.00114 24966834; PubMed Central PMCID: PMCPMC4053654.
33. Heeney MM, Finberg KE, Iron-refractory iron deficiency anemia (IRIDA). Hematol Oncol Clin North Am. 2014;28(4):637–52, v. doi: 10.1016/j.hoc.2014.04.009 25064705.
34. Schuster V, Hugle B, Tefs K, Plasminogen deficiency. J Thromb Haemost. 2007;5(12):2315–22. doi: 10.1111/j.1538-7836.2007.02776.x 17900274.
35. Law RH, Caradoc-Davies T, Cowieson N, Horvath AJ, Quek AJ, Encarnacao JA, et al. The X-ray crystal structure of full-length human plasminogen. Cell Rep. 2012;1(3):185–90. doi: 10.1016/j.celrep.2012.02.012 22832192.
36. Martin-Fernandez L, Marco P, Corrales I, Perez R, Ramirez L, Lopez S, et al. The Unravelling of the Genetic Architecture of Plasminogen Deficiency and its Relation to Thrombotic Disease. Sci Rep. 2016;6:39255. doi: 10.1038/srep39255 27976734; PubMed Central PMCID: PMCPMC5157013.
37. Tefs K, Gueorguieva M, Klammt J, Allen CM, Aktas D, Anlar FY, et al. Molecular and clinical spectrum of type I plasminogen deficiency: A series of 50 patients. Blood. 2006;108(9):3021–6. doi: 10.1182/blood-2006-04-017350 16849641.
38. Demarmels Biasiutti F, Sulzer I, Stucki B, Wuillemin WA, Furlan M, Lammle B, Is plasminogen deficiency a thrombotic risk factor? A study on 23 thrombophilic patients and their family members. Thromb Haemost. 1998;80(1):167–70. 9684804.
39. Reiner AP, Aramaki KM, Proteolytic modulation of thrombopoietin activity: comparison of thrombin, plasmin, and urokinase. Thromb Haemost. 2000;83(6):909–14. 10896248.
40. Kuliopulos A, Covic L, Seeley SK, Sheridan PJ, Helin J, Costello CE, Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Biochemistry. 1999;38(14):4572–85. doi: 10.1021/bi9824792 10194379.
41. Quinton TM, Kim S, Derian CK, Jin J, Kunapuli SP, Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4. J Biol Chem. 2004;279(18):18434–9. doi: 10.1074/jbc.M401431200 14973136.
42. Blavignac J, Bunimov N, Rivard GE, Hayward CP, Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment. Semin Thromb Hemost. 2011;37(6):713–20. doi: 10.1055/s-0031-1291382 22102275.
43. Tajuddin SM, Schick UM, Eicher JD, Chami N, Giri A, Brody JA, et al. Large-Scale Exome-wide Association Analysis Identifies Loci for White Blood Cell Traits and Pleiotropy with Immune-Mediated Diseases. Am J Hum Genet. 2016;99(1):22–39. doi: 10.1016/j.ajhg.2016.05.003 27346689; PubMed Central PMCID: PMCPMC5005433.
44. Winkler TW, Day FR, Croteau-Chonka DC, Wood AR, Locke AE, Magi R, et al. Quality control and conduct of genome-wide association meta-analyses. Nat Protoc. 2014;9(5):1192–212. doi: 10.1038/nprot.2014.071 24762786; PubMed Central PMCID: PMC4083217.
45. Limongelli G, Elliott P, Charron P, Mogensen J, McKeown PP, Approaching genetic testing in cardiomyopathies. ESC Council for Cardiology Practice. 2012.
46. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT, Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science. 1998;280(5364):750–2. 9563954.
47. Loh PR, Tucker G, Bulik-Sullivan BK, Vilhjalmsson BJ, Finucane HK, Salem RM, et al. Efficient Bayesian mixed-model analysis increases association power in large cohorts. Nat Genet. 2015;47(3):284–90. doi: 10.1038/ng.3190 25642633; PubMed Central PMCID: PMCPMC4342297.
48. Willer CJ, Li Y, Abecasis GR, METAL: Fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26(17):2190–1. Epub 2010/07/10. doi: 10.1093/bioinformatics/btq340 20616382.
49. Dawber TR, Meadors GF, Moore FE, Jr.Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health. 1951;41(3):279–81. Epub 1951/03/01. 14819398; PubMed Central PMCID: PMC1525365.
50. Grove ML, Yu B, Cochran BJ, Haritunians T, Bis JC, Taylor KD, et al. Best practices and joint calling of the HumanExome BeadChip: the CHARGE Consortium. PLoS One. 2013;8(7):e68095. doi: 10.1371/journal.pone.0068095 23874508; PubMed Central PMCID: PMCPMC3709915.
51. Johnson AD, Yanek LR, Chen MH, Faraday N, Larson MG, Tofler G, et al. Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet. 2010;42(7):608–13. doi: 10.1038/ng.604 20526338; PubMed Central PMCID: PMCPMC3057573.
52. Huffman JE, de Vries PS, Morrison AC, Sabater-Lleal M, Kacprowski T, Auer PL, et al. Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF. Blood. 2015;126(11):e19–29. doi: 10.1182/blood-2015-02-624551 26105150; PubMed Central PMCID: PMCPMC4566813.
53. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355(25):2631–9. doi: 10.1056/NEJMoa055373 17182988.
54. Tofler GH, Massaro J, O'Donnell CJ, Wilson PW, Vasan RS, Sutherland PA, et al. Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study. Thromb Res. 2016;140:30–5. doi: 10.1016/j.thromres.2016.02.002 26896607.
55. Huang da W, Sherman BT, Lempicki RA, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. doi: 10.1038/nprot.2008.211 19131956.